Self-Emulsifying Formulations: A Pharmaceutical Review
The oral route of drug delivery is commonly utilized for administration of medicines and is particularly preferred for the treatment of many chronic diseases which require continuous ingestion over a reasonably prolonged period of time. However the oral delivery of lipophilic drugs presents a major obstacle because of their low aqueous solubility. The aqueous solubility of a drug is a crucial determinant of its dissolution rate, absorption and bioavailability. Drugs with relatively high intrinsic lipophilicity can be dissolved in appropriate mixtures of oils/lipids, surfactants, cosolvents which can rapidly form oil-in-water (o/w) fine emulsions when dispersed in aqueous phase under mild agitation or mixing. These isotropic self-emulsifying formulations or self-emulsifying drug delivery systems are effective for delivery of poorly soluble, lipophilic drugs by dispersing the drugs within fine oil droplets in emulsions and this solubilization of drugs can then improve its absorption, bioavailability and therapeutic efficacy. The present paper reviews the concept, design, formulation, characterization and applications of self-emulsifying formulations.
Keywords: Self-Emulsifying Formulations, lipophilicity, emulsions
2. Wakerly MG, Pouton CW, Meakin BJ. Evaluation of the self emulsifying performance of a non ionic surfactant-vegetable oil mixture. J Pharm Pharmacol 1987; 39:6.
3. Fahy E, Subramaniam S, Murphy R, Nishijima M, Raect C, Shimizu T, Spener F, Van Meer G, Wakelam M, Dennis EA. Update of the LIPID MAPS comprehensive classification system for lipids. J Lipid Res 2009; 50 (supplement):59–514.
4. Subramaniam S, Fahy E, Gupta S, Sud M, Byrnes RW, Cotter D, Dinasarapu AR, Maurya MR. Bioinformatics and systems biology of the lipidome. Chem Rev 2011; 111 (10):6452–6490.
5. Djekic L, Primorac M. The Influence of cosurfactants and oils on the formation of pharmaceutical microemulsions based on PEG-8 caprylic/capric glycerides. Int J Pharm 2008; 352:231-239.
6. Tsevegsuren N, Aitzetmuller K, Bruhl L, Werner G. Seed oil fatty acids of Mongolian compositae: The trans fatty acids of Heteropappus hispidus, Asterothamnus centrali-asiaticus and Artemisia palustris. J High Resol Chromatogr 2000; 23:360–366.
7. Bell SJ, Bradley D, Forse RA, Bistrian BR. The new dietary fats in health and disease. J Am Diet Assoc 1997; 97:280–286
8. Schneider M. Industrial production of phospholipids – lecithin processing. Lipid Technology 1997:109-116.
9. Stuchlik M, Zaks S. Lipid-based vehicle for oral drug delivery. Biomed Papers 2001; 154(2):17–26.
10. Mistry RB, Sheth NS. A Review: Self emulsifying drug delivery system. International Journal of Pharmacy and Pharmaceutical Sciences 2011; 3 (2):23-28.
11. Constantinides PP. Lipid microemulsions for improving drug dissolution and Oral absorption: Physical and biopharmaceutical aspects. Pharm. Res 1995; 12:1561-1572.
12. Groves MJ, Mustata RMA. Measurement of spontaneity of self-emulsifiable oils. J Pharm Pharmacol 1974; 26:671-688.
13. Jannin V, Musakhanian J, Marchaud D. Approaches for the development of solid and semi solid lipid based formulations. Adv Drug Deliv Rev 2007; 60:734-746.
14. Serajuddin A.T.M. Solid dispersion of poorly watersoluble drugs: early promises, subsequent problems, and recent breakthroughs. J. Pharm. Sci. 1999; 88:1058–1066
15. Helfrich W. Elastic properties of lipid bilayers: Theory and possible experiments. Z. Naturforsch, 1973; 28c:693-703
16. Bancroft W.D. The theory of emulsification V. Journal of Physical Chemistry 1913; 17:501-519
17 Israelachvili JN. Theory of self-assembly of hydrocarbon amphiphiles into micelles and bilayers. Journal of the Chemical Society, Faraday Transactions 2: Molecular and Chemical Physics 72:1525-1568
18. Agubata C.O, Nzekwe I.T, Obitte N.C, Ugwu C.E, Attama A.A, Onunkwo G.C. Effect of oil, surfactant and co-surfactant concentrations on the phase behavior, physicochemical properties and drug release from self-emulsifying drug delivery systems. Journal of Drug discovery, Development and Delivery 2014; 1:1-7.
19. Pouton CW. Formation of self-emulsifying drug delivery System. Adv Drug Deliv Rev 1997; 25:47-58.
20. El Laithy HM. Self-nanoemulsifying drug delivery system for enhanced bioavailability and improved hepatoprotective activity of biphenyl dimethyl dicarboxylate. Curr. Drug Del 2008; 5:170-176.
21. Benet L. The drug efflux- metabolism alliance biochemical aspects. Adv Drug Deliv Rev 2001; 50:S3-S11.
22. Devani M, Ashford M, Craig DQ. The emulsification and solubilisation properties of polyglycolysed oils in self-emulsifying formulations. J Pharm Pharmacol 2004; 56:307-316.
23. Huass DJ, Fogal SE, Ficorilli JV, Price CA, Roy T, Jayaraj AA, Keirns JJ. Lipid based delivery systems for improving the bioavailability and lymphatic transport of poorly water soluble LTB4 inhibitor. J Pharm Sci 1998; 87(2):164-169.
24. Caliph SM, Charman WN, Porter CJ. Effect of short-, medium- and long chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph cannulated and non cannulated rats. J Pharm Sci 2000; 89:1073-1084.
25. Charman WN, Stella VJ. Transport of lipophilic molecules by the intestinal lymphatic system. Adv Drug Deliv Rev 1991; 7:1-14.
26. Pouton CW. Lipid formulations for oral administration of drugs. Non-emulsifying, self emulsifying and self microemulsifying drug delivery systems. Eur J Pharm Sci 2000; 11:S93-98.
27. Tang JL, Sun J, and He ZG. Self-emulsifying drug delivery systems: strategy for improving oral delivery of poorly soluble drugs. Current Drug Therapy 2007; 2 (1):85–93.
28. Dahan A, Hoffman A. Rationalising the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs. J Control Rel 2008; 129:1-10.
29. Antron N, Vandamme TF. The universality of low energy nanoemulsification. Int J Pharm 2009; 377:142-147.
30. Aungst BJ. Intestinal permeation enhancers. J Pharm Sci 2000; 89:429-442.
31. Talegaonkar S, Azeem A, Ahmad FJ, Khar RK, Pathan SA, Khan ZI. Microemulsion: A novel approach to enhanced drug delivery. 238 Recent Patents on Drug Delivery and Formulation 2008; 2:238-257.
32. Bagwe RP, Kanicky JR, Palla BJ, Patanjali PK, Shah DO. Improved drug delivery using microemulsions: rationale, recent progress, and new horizons. Critical Reviews in Therapeutic Drug Carrier Systems 2001; 18 (1): 77–140.
33. Meinzer A, Mueller E, Vonderscher J. Microemulsion- A suitable galenical approach for the absorption enhancement of a low soluble compound? BT Gattefosse 1995; 88:21-26.
34. Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery system. Adv Drug Deliv Rev 2000; 45:89-121.
35. Kahlweit M. Microemulsions. Annu. Rep. Prog. Chem-sect. C. 1999; 95:89-115.
36. Bhargava HN, Narurkar A, Lieb LM. Using microemulsions for drug delivery. Pharm Tech 1987; 11:46-52.
37. Karim A, Gokhale R, Cole M, Sherman J, Yeramian P, Bryant M, Franke H. HIV protease inhibitor SC-52151: a novel method of optimizing bioavailability profile via a microemulsion drug delivery system. Pharm Res 1994; 11:S368.
38. Georgakopoulos E, Farah N, Vergnault G. Oral anhydrous non-ionic microemulsions administered in softgel capsules. B T Gattefosse 1992; 85:11-20.
39. Cui J, Yu B, Zhao Y, Zhu W, Li H, Lou H, Zhai G. Enhancement of oral absorption of curcumin by self microemulsifying drug delivery systems. Int J Pharm 2009; 371:148-155.
40. Thi TD, Van Speybroeck M, Barillaro V, Martens J, Annaert P, Augustijns P, Van Humbeeck J, Vermant J, Van den Mooter G. Formulate-ability of ten compounds with different physicochemical profiles in SMEDDS. Eur J Pharm Sci 2009; 38: 479-488.
41. Patel PA, Chaulang GM, Akolkotkar A, Mutha SS, Hardikar SR, Bhosale AV. Self emulsifying drug delivery systems: A review. Research J. Pharm and Tech. 2008; 1(4):313-323.
42. Porter CJ, Charman WN. In vitro assessment of oral lipid based formulations. Adv Drug Deliv Rev 2001; 50 suppl 1: S127-47.
43. Komuru TR, Gurley B, Khan MA, Reddy IK. Self-emulsifying drug delivery systems (SEDDS) of Co enzyme Q 10: formulation development and bioavailability assessment. Int J Pharm 2001; 212:233–246.
44. MacGregor KJ, Embleton JK, Lacy JE, Perry EA, Solomon LJ, Seager H, Pouton CW. Influence of lipolysis on drug absorption from the gastrointestinal tract. Adv Drug Deliv Rev 1997; 25:33-46.
45. Embleton JK, Pouton CW. Structure and activity of gastrointestinal lipases. Adv Drug Deliv Rev 1997; 25:15-32.
46. Date AA, Nagarsenker MS. Design and evaluation of self nanoemulsifying drug delivery system (SNEDDS) for cefpodoxime proxetil. Int J Pharm 2007; 329:166-172.
47. Wang L, Dong J, Eastoc J, LI X. Design and optimization of a new self-nanoemulsifying drug delivery system. J Colloid Interface Sci 2009; 330:443-448.
48. Dixit RP, Nagarsenker MS. Formulation and in vivo evaluation of self-nano emulsifying granules for oral drug delivery of a combination of ezetimibe and simvastatin. Drug Dev Ind Pharm 2008; 34:1285-1296.
49. Shah NH, Carvajal MT, Patel CJ, Infeld MH, Malick AW. Self emulsifying drug delivery systems (SEDDS) with polyglycolized glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int J Pharm 1994; 106:15-23.
50. Lievens HSR, Craig DQM, Pitt KG, Storey DE. An investigation into physico-chemical properties of self-emulsifying systems using low frequency dielectric spectroscopy, surface tension measurement and particle size analysis. Int J Pharm 1993; 96:147-55.
51. Baboota S, Shakeel F, Ahuja A, Ali J, Shafiq S. Design, development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxib. Acta Pharm. 2007; 57:315-332.
52. Maurya SD, Arya RKK, Rajpal G, Dhakar RC, Self-micro emulsifying drug delivery systems (SMEDDS): a review on physico-chemical and biopharmaceutical aspects, Journal of Drug Delivery and Therapeutics 2017; 7(3):55-65
53. Lachman L, Lieberman, HA. The theory and practice of industrial pharmacy, CBS Publishers, New Delhi, special Indian edition, 2009; p 772.
54. Suman K, VSR Chandrasekhar P, Balaji S. Approaches for the development of solid self emulsifying drug delivery systems and dosage forms. Asian J Pharm Sci 2009; 4 (4): 240-253.
55. Rodriguez L, Passerini N, Cavallari C, Albertini B, Fini A. Description and preliminary evaluation of a new ultrasonic atomizer for spray-congealing processes. Int J Pharm 1999; 183 (2):133-143.
56. Yi T, Wan JL, Xu HB, Yang X. A new solid self microemulsifying formulation prepared by spray-drying to improve the oral bioavailability of poorly water soluble drugs. Eur J Pharm Biopharm 2008; 70:439-444.
57. Ito Y, Kusawake T, Ishida M, Tawa R, Shibata N, Takada K. Oral solid gentamicin preparation using emulsifier and adsorbent. J Control Rel 2005; 105 (1-2):23-31.
58. Verreck G, Brewster ME. Melt extrusion based dosage forms: Excipients and processing conditions for pharmaceutical formulations. Bull Tech Gattefosse 2004; 97:85-95.
59. Ribeiro Dos Santos I, Thies C, Richard J, Le Meurlay D, Gajan V, Vandevelde V, Benoit JP. A supercritical fluid based coating technology 2: solubility considerations. J Microencapsul 2003; 20 (1):97-109.
60. Toorisaka E, Haashida M, Kamiya N, Ono H, Kokazu Y, Goto M. An enteric coated dry emulsion formulation for insulin delivery. J Control Rel 2005; 107:91-96.
61. Rao SV, Agarwal P, Shao J. Self nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of protein drugs: II. In vitro transport study. Int J Pharm 2008; 362:10-15.
62. Patil P. Effect of formulation variables on preparation and evaluation of gelled self-emulsifying drug delivery system (SEDDS) of ketoprofen. AAPS Pharm Sci Tech 2004; 5:34-42.
63. Arida AI, Moawia MA, Hantash AJ, Moawia MA, Hantash AJH. Improving the high variable bioavailability of griseofulvin by SEFs. Chem Pharm Bull 2007; 55:1713-1719.
64. Balakrishnan P, Lee BJ, Lee YI, Woo JS, Yong CS, Choi HG. Enhanced oral bioavailability of coenzyme Q10 by self-emulsifying drug delivery systems. Int J Pharm 2009; 374:66-72.
65. Attama AA, Nzekwe IT, Nnamani PO, Adikwu MU, Onugu CO. The use of solid self- emulsifying system in the delivery of diclofenac. Int J Pharm 2003; 262:23-28.
66. Khoo S, Humberston AJ, Porter CJH, Edwards GA, Charman WN. Formulation, design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine. Int J Pharm 1998; 167:155-164.
67. Qi X, Wang L, Zhu J, Hu Z, Zhang J. Self-double-emulsifying drug delivery system (SDEDDS): A new way for oral delivery of drugs with high solubility and low permeability. Int J Pharm 2011; 409:245-251.
68. Shanmugam S, Park J, Kim KS, Piao ZZ, Youg CS, Choi H, Woo JS. Enhanced bioavailability and retinal accumulation of lutein from self-emulsifying phospholipid suspension (SEPS). Int J Pharm 2001; 412:99-105.
69. Gershanik T, Haltner E, Lehr CM, Benita S. Charge dependent interaction of self-emulsifying oil formulations with Caco-2 cells nanolayers; binding effects on barrier function and cytotoxicity. Int J Pharm 2000; 211:29-36.
70. Corbo DC, Liu JC, Chien YW. Characterization of the barrier properties of mucosal membranes. J Pharm Sci 1990; 79:202-206.
71. Trickler WJ, Nagvekar AA, Dash AK . A novel nanoparticle formulation for sustained paclitaxel delivery. AAPS Pharm Sci Tech 2008; 9 (2):486-493.
72. Singnurkar PS, Gidwani SK. Insulin- egg yolk dispersions in self-microemulsifying system. Indian J Pharm Sci 2008; 70(6):727-732.
73. Zhaoa Y, Wanga C, Chowh AHL, Renc K, Gongc T, Zhangc Z, Zhenga Y. Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of zedoary essential oil: formulation and bioavailability studies. Int J Pharm 2010; 383:170-177.
74. You, J. Study of the preparation of sustained-release microspheres containing zedoary turmeric oil by the emulsion-solvent-diffusion method and evaluation of the self-emulsification and bioavailability of the oil. Colloids Surf. B Biointerfaces 2006; 48:35-41.
75. Nepal PR, Han HK, Choi HK. Preparation and in vitro-in vivo evaluation of Witepsol® H35 based self-nanoemulsifying drug delivery systems (SNEDDS) of coenzyme Q10. Eur J Pharm Sci 2010; 39:224-232.
76. Koynova R, Mariana T. Nanosized self-emulsifying lipid vesicles of diacylglycerol-PEG lipid conjugates: Biophysical characterization and inclusion of lipophilic dietary supplements. biochim biophys acta 2010; 1798:646-653.
77. Franceschinis E, Voinovich D, Grassi M, Perissutti Filipovic-grcic BJ, Martinac A, Meriani-merlo F. Self-emulsifying pellets prepared by wet granulation in high-shear mixer: influence of formulation variables and preliminary study on the in vitro absorption. Int J Pharm 2005; 291:87-97.
78. Tuleu C. Comparative bioavailability study in dogs of a self-emulsifying formulation of progesterone presented in a pellet and liquid form compared with an aqueous suspension of progesterone. J Pharm Sci 2004; 93: 1495-1502.
79. Wang Z, Sun J, Wang Y, Liu X, Liu Y, Fu Q, Meng P, He Z. Solid self-emulsifying nitrendipine pellets: preparation and in vitro/in vivo evaluation. Int J Pharm 2010; 383:1-6.
80. Serratoni M, Newton M. Controlled drug release from pellets containing water-insoluble drugs dissolved in a self-emulsifying system. Eur J Pharm Biopharm 2007; 65:94-98.
81. Patil P, Paradkar A. Porous polystyrene beads as carriers for self-emulsifying system containing loratadine. AAPS Pharm Sci Tech 2006; 7:E1-E7.
82. Chae GS, Lee JS, Kim SH. Enhancement of the stability of BCNU using self-emulsifying drug delivery systems (SEDDS) and in vitro antitumor activity of self-emulsified BCNU-loaded PLGA wafer. Int J Pharm 2005; 301:6-14.
83. Agubata CO, Onwumere OC, Oraeluno JN, Obasi JC, Chidebelu CC, Akpa PA. Self-emulsifying solid lipid microparticles of glibenclamide based on amphiphilic non-ionic caprylocaproyl macrogol-8-glyceride. International Journal of Modern Pharmaceutical Research 2019; 3(6):22-30
84. Poelma FG, Breas R, Tukker JJ, Crommelin DJ. Intestinal absorption of drugs. The influence of mixed micelles on the disappearance kinetics of drugs from the small intestine of the rat. J Pharm Pharmacol 1991; 43:317-324.
85. Pellet MA, Davis AF, Hadgraft J. Effect of supersaturation on membrane transport: 2. piroxicam. Int J Pharm 1994; 111:1-6.
86. Gao P, Guyton ME, Huang T, Bauer JM, Stefanski KJ, Lu Q. Enhanced oral bioavailability of a poorly water soluble drug PNU-91325 by supersaturable formulations. Drug Dev Ind Pharm 2004; 30:221-229.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).